Status:
COMPLETED
S100β and Neuron Specific Enolase Levels in Liver Transplantation
Lead Sponsor:
Bora Dinc
Conditions:
Liver Transplantation
Eligibility:
All Genders
18+ years
Brief Summary
Several neurological problems which include both central nervous system and peripheral nervous system can occur as a result of acute liver failure or severe chronic liver failure. The main reason of c...
Detailed Description
Neurologic disorders that affect the liver transplantation candidates when they are on the waitlist not only significantly affect preoperative morbidity and even mortality but also present important p...
Eligibility Criteria
Inclusion
- All liver transplantation candidates shall be accepted into the study.
Exclusion
- Patients who:
- Refused the study With infection, oncological and hematological diseases, coronary or kidney failure, malnutrition or skull fracture The ones who were transplanted liver from cadaveric Using psychoactive medicine Having respiratory system or central nerve system disease shall be excluded from the study.
Key Trial Info
Start Date :
June 20 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 20 2021
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT03453047
Start Date
June 20 2017
End Date
May 20 2021
Last Update
July 28 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Akdeniz University Medical Faculty Department of Anesthesiology and Reanimation
Antalya, Turkey (Türkiye), 07059